<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 22, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00568438</url>
  </required_header>
  <id_info>
    <org_study_id>BRSNSTU0011</org_study_id>
    <secondary_id>75622</secondary_id>
    <secondary_id>11005</secondary_id>
    <nct_id>NCT00568438</nct_id>
  </id_info>
  <brief_title>Immunohistochemical &amp; Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival &amp; Frozen Tissue Sample</brief_title>
  <official_title>Immunohistochemical &amp; Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival and Frozen Human Tissue Samples</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to study NIS expression in benign and malignant breast and thyroid
      samples using archival formalin-fixed paraffin-embedded tissue sections.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the study is to further understanding of proteins that occur in both normal
      cells and tumor cells and to learn more about certain diseases and potential alternative
      treatments for these diseases.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2000</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Stomach Neoplasms</condition>
  <condition>Salivary Gland Neoplasms</condition>
  <condition>Thyroid Cancer</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cases will be identified from clinic patient medical records and linked to pathology
      reports. The surgical pathology record number will thus be obtained and used to retrieve the
      archival blocks and slides. Approximately three representative blocks will be selected and
      4-6 four micron thick sections will be cut on a microtome. Cases with limited archived
      diagnostic material will not be selected nor blocks where there is little materials.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Cases will be identified from clinic patient medical records and linked to pathology
        reports. The surgical pathology record number will thus be obtained and used to retrieve
        the archival blocks and slides. In addition, all these participants will be clinical
        patients of the Protocol Director, thus the Physician will always be familiar with the
        participants.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient must be over the age of 18.

          2. Patients must have benign and malignant breast and thyroid cancer.

          3. Patient mus sign consent form.

        Exclusion Criteria:

        1. No children will be allowed.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irene L. Wapnir</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irene Wapnir</last_name>
      <phone>650-736-1353</phone>
      <email>irene.wapnir@stanford.edu</email>
    </contact>
    <contact_backup>
      <last_name>Cancer Clinical Trials Office</last_name>
      <phone>(650) 498-7061</phone>
    </contact_backup>
    <investigator>
      <last_name>Irene L. Wapnir</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ralph S. Greco MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kent W Nowels</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>April 14, 2016</lastchanged_date>
  <firstreceived_date>December 4, 2007</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Salivary Gland Neoplasms</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
